IndraLab

Statements


| 1

reach
"The ability of the PPAR-gamma agonist to inhibit IFN-beta production was confirmed in vivo as mice treated with troglitazone exhibited decreased levels of IFN-beta upon LPS and poly (I : C) challenge."